City
Epaper

Taiwan's deal to receive 5 mln Pfizer-BioNTech COVID-19 vaccines foiled by outside sources, says Minister

By ANI | Updated: February 18, 2021 04:40 IST

Taiwan was close to receiving 5 million doses of the Pfizer-BioNTech COVID-19 vaccine late last year but the deal was called off due to interferences from outside sources, said Chen Shih-Chung, Taiwan Health Minister.

Open in App

Taiwan was close to receiving 5 million doses of the Pfizer-BioNTech COVID-19 vaccine late last year but the deal was called off due to interferences from outside sources, said Chen Shih-Chung, Taiwan Health Minister.

Speaking on a local radio show on Wednesday, Chen said that Taiwan had started reaching out to the international compes, who were developing vaccines against the coronavirus, in June last year.

By December, Taiwan was close to securing 5 million doses of the COVID-19 vaccine developed by the American pharmaceutical company Pfizer and German biotech firm BioNTech (BNT) through direct negotiations with BNT, Focus Taiwan quoted him Chen as saying.

He said, "We were at the final step in the process, and we had already written and read each other's press releases," but "Maybe someone did not want Taiwan to be too happy".

However, he refused to tell any details on what the BNT had said when the deal fell off.

According to Fous Taiwan, the show's host, Clara Chou, speculated without citing any sources that the interference came from China and the Shanghai Fosun Pharmaceutical Group, a Chinese company that is BNT's agent for the COVID-19 vaccine in mainland China, Hong Kong, Macao and Taiwan.

On December 30, Chen had announced that 5 million doses of vaccine against coronavirus have been secured from an international company.

However, he was criticised at the time for not being transparent about the vaccine issue, though Chen said he was in reality "suffering in silence", Focus Taiwan reported.

Meanwhile, Taiwan, to date, has secured 14.76 million doses of the Oxford-AstraZeneca vaccine and 5 million doses of the COVID-19 vaccine produced by US company Moderna.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: BioNTech SEClara choutaiwanHong KongPfizerPfizer inc.
Open in App

Related Stories

NationalAir India Flight to Delhi Returns to Hong Kong After Pilots Detect Possible Technical Problem

NationalCOVID-19 Situation in India Under Control, Say Official Sources Amid Scare in Singapore, Hong Kong

MumbaiMumbai; BMC Issues Advisory After Two COVID-19 Deaths, Assures Public of Preparedness

InternationalTariff War: US Postal Service Suspends Incoming Packages From China and Hong Kong

InternationalNew Year's Hong Kong to Los Angeles Flight Takes Passengers Back in Time, Departs in 2025 and Lands in 2024

International Realted Stories

InternationalTrump threatens to 'substantially' raise tariffs on India for buying Russian oil 

InternationalTrump warns of "substantially raising tariff paid by India" over Russian oil import

InternationalIran to consider any nuclear proposal securing uranium enrichment right

InternationalTrump threatens to substantially raise tariff on India over Russian oil purchase

InternationalStorm Floris batters northern UK with dangerous winds, heavy rain